983P Camrelizumab (C) in combination with apatinib (A) in patients with advanced hepatocellular carcinoma (RESCUE): An open-label, multi-center, phase II trialJ. Xu, Qi Wang, Jie Shen et al.|Annals of Oncology|2020Cited by 5
E3 ligase FBXO2-mediated protein stability of insulin receptor regulates adipogenesis and metabolic health in obesityYan Gao, Dongliang Fang, Muchen Wu et al.|Research Square|2025Cited by 0